Nuvation Bio Inc. (NUVB) Reports In-Line Q1 EPS

Nuvation Bio Inc. (NYSE: NUVB) reported Q1 EPS of $0.01, in-line with the analyst estimate of $0.01. Revenue for the quarter came in at $83.23 million versus the consensus estimate of $66.22 million.

For earnings history and earnings-related data on Nuvation Bio Inc. (NUVB) click here.

You May Also Be Interested In

• J Capital Research cautious on Microchip: 'riding high on AI hype but looks weak'
• Darden Restaurants (DRI) call put ratio 1.9 calls to 1 put as share price up 2.6% into the expected release of quarter results
• 5.5 magnitude earthquake strikes Northern California - EMSC